Tissue factor-dependent coagulation activation and impaired fibrinolysis in situ in gastric cancer

MZ Wojtukiewicz, E Sierko, LR Zacharski… - … in Thrombosis and …, 2003 - thieme-connect.com
Thromboembolism frequently complicates gastric cancer. This study examined the solid
phase interaction between gastric cancer and coagulation proteins in situ that may explain …

[引用][C] Fibrinolytic markers of clinical evolution in tumour patients

BR Binder - Fibrinolysis, 1993 - Elsevier
fll must be released from this complex to interact with its plasma membrane receptor and
elicit a biological response. Plasmin is an efficient activator of latent TGF-01 both in vitro and …

Fibrinogen deposition without thrombin generation in primary human breast cancer tissue

V Costantini, LR Zacharski, VA Memoli, W Kisiel… - Cancer Research, 1991 - AACR
The occurrence and distribution of components of coagulation pathways in situ were
determined using immunohistochemical techniques applied to 10 cases of primary …

[引用][C] Localization of fibrinolytic activity in uterine cancer

G Weiss, FK Beller - American Journal of Obstetrics and Gynecology, 1969 - Elsevier
Four specimens of invasive endometrial adenocarcinoma and five specimens of locally
invasive squamous cell carcinoma of the cervix were studied for fibrinolytic activity by Todd's …

Cancer and thromboembolic disease: pathogenic mechanisms

AY Lee - Cancer treatment reviews, 2002 - Elsevier
Almost all types of cancer are associated with an activation of coagulation. However,
elevation of haemostatic markers of coagulation does not predict venous thrombosis …

Increased fibrin formation with tumours and its genesis

JJ Franks, SG Gordon, B Kao, T Sullivan… - Plasma Protein Turnover, 1976 - Springer
O'Meara and his associates 1–5 and Clarke 6 showed over ten years ago that malignant
tissues produce a lipid containing coagulative factor which can diffuse out of cells, initiate …

Pathogenesis of venous thromboembolic disease in cancer

I Elalamy, E Verdy, G Gerotziafas, M Hatmi - Pathologie-biologie, 2008 - europepmc.org
Cancer is a real model of acquired hypercoagulable state. A close interaction exists
between venous thromboembolic disease and cancer. Tumor progression is associated with …

Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human …

M Shoji, WW Hancock, K Abe, C Micko… - The American journal …, 1998 - ncbi.nlm.nih.gov
Thrombin-catalyzed, cross-linked fibrin (XLF) formation is a characteristic histopathological
finding in many human and experimental tumors and is thought to be of importance in the …

[引用][C] Pathways of blood clotting initiation by cancer cells

N Semeraro, MB Donati - Malignancy and the hemostatic …, 1981 - Raven Press New York

Mechanisms linking tumor cell-associated procoagulant function to tumor metastasis

JS Palumbo, JL Degen - Thrombosis research, 2007 - Elsevier
A link between the hemostatic system and cancer biology was first suggested by Trousseau
[1] more than a century ago with the observation that hemostatic derangements, such as …